本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Day One Biopharmaceuticals Inc.

7.44
+0.11001.50%
盘后7.40-0.0400-0.54%18:12 EDT
成交量:89.73万
成交额:675.36万
市值:7.54亿
市盈率:-7.26
高:7.74
开:7.51
低:7.39
收:7.33
数据加载中...
2024/02/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/16

重要事件披露

Form 8-K - Current report
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/30

重要事件披露

Form 8-K - Current report
2023/10/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/11

重要事件披露

Form 8-K - Current report